logo-loader
viewIntegumen

Integumen signs material transfer agreement with Aptamer Group for new coronavirus kit

Integumen PLC's (LON:SKIN) Gerry Brandon caught up with Proactive London's Andrew Scott after signing a material transfer agreement (MTA) with a company called Aptamer Group that will allow the pair to develop and manufacture a kit to detect SARS-CoV-2 in wastewater. Integumen believes aptamers have the potential to play a key role in the real-time identification of localised coronavirus hotspots in wastewater, helping curb the spread of the virus.

Quick facts: Integumen

Price: 1.9569 GBX

AIM:SKIN
Market: AIM
Market Cap: £21.11 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Integumen named herein, including the promotion by the Company of Integumen in any Content on the Site, the Company receives from said issuer...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Integumen's Gerry Brandon outlines collaboration with Avacta for real-time...

Integumen PLC's (LON:SKIN) Gerry Brandon caught up with Proactive London's Andrew Scott after announcing a collaboration with Avacta PLC (LON:AVCT) to use their technology in a coronavirus (COVID-19) detection kit. He says they've signed a material transfer agreement to use recently-generated...

3 hours, 38 minutes ago

2 min read